Form 8-K - Current report:
SEC Accession No. 0001104659-13-045516
Filing Date
2013-05-30
Accepted
2013-05-30 08:09:24
Documents
3
Period of Report
2013-05-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-14058_18k.htm 8-K 21683
2 EX-99.1 a13-14058_1ex99d1.htm EX-99.1 11044
3 EX-99.2 a13-14058_1ex99d2.htm EX-99.2 9332
  Complete submission text file 0001104659-13-045516.txt   43370
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 13879930
SIC: 2834 Pharmaceutical Preparations